UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000013126
Receipt number R000015266
Scientific Title Optimal pretreatment for observing stomach lumen while under water using capsule endoscopy.
Date of disclosure of the study information 2014/02/14
Last modified on 2014/06/28 12:39:11

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Optimal pretreatment for observing stomach lumen while under water using capsule endoscopy.

Acronym

Optimal pretreatment for gastric capsule endoscopy.

Scientific Title

Optimal pretreatment for observing stomach lumen while under water using capsule endoscopy.

Scientific Title:Acronym

Optimal pretreatment for gastric capsule endoscopy.

Region

Japan


Condition

Condition

Helicobacter Pylori related gastritis

Classification by specialty

Gastroenterology

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

To evaluate the optimal pretreatment for observing stomach lumen while under water using capsule endoscopy.

Basic objectives2

Efficacy

Basic objectives -Others


Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

Efficacy
1)Primary: Quality of pretreatment
A) Transparency of fluid in the stomach
B) Level of mucus and bubbles in the fluid
2)Second: Extensibility of the stomach
Safety
1) Adverse event
2) Symptoms
3) Physical examination
4) Physiological examination

Key secondary outcomes



Base

Study type

Interventional


Study design

Basic design

Single arm

Randomization

Non-randomized

Randomization unit


Blinding

Open -no one is blinded

Control

Uncontrolled

Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms

1

Purpose of intervention

Prevention

Type of intervention

Medicine Device,equipment

Interventions/Control_1

aa

Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

20 years-old <=

Age-upper limit

65 years-old >

Gender

Male and Female

Key inclusion criteria

Patients who fills everything the following
1)Patients of 20 yo or more, less than 65 yo.
2)Patients who gives written informed consent.
3)Patients who were judged as qualified subject with normal blood pressure/pulse rate.
4)Patients who were diagnosed whether Helicobacter pylori was positive or negative confirmed by urea breath test

Key exclusion criteria

1)Patients who has past history of allergy for Lidocaine
2)Patients who join other study
3)Patients who can not observe the rule of this study.
4)Pregnant females
5)Patient whom examination doctor judged improper as testee

Target sample size

40


Research contact person

Name of lead principal investigator

1st name
Middle name
Last name Atsushi Irisawa

Organization

Fukushima Medical University Aizu Medical Center.

Division name

Department of Gastroenterology

Zip code


Address

21-2, Maeda, Tanisawa, Kawahigashi, Aizuwakamatsu, 969-3492. Japan.

TEL

0242-75-2100

Email

irisawa@fmu.ac.jp


Public contact

Name of contact person

1st name
Middle name
Last name Atsushi Irisawa

Organization

Fukushima Medical University Aizu Medical Center.

Division name

Department of Gastroenterology

Zip code


Address

21-2, Maeda, Tanisawa, Kawahigashi, Aizuwakamatsu, 969-3492. Japan.

TEL

0242-75-2100

Homepage URL


Email

irisawa@fmu.ac.jp


Sponsor or person

Institute

Souseikai medical corporation, Clinic HAKATA.

Institute

Department

Personal name



Funding Source

Organization

Fukushima Medical University

Organization

Division

Category of Funding Organization

Self funding

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization


Address


Tel


Email



Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions

医療法人相生会 博多クリニック


Other administrative information

Date of disclosure of the study information

2014 Year 02 Month 14 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Completed

Date of protocol fixation

2014 Year 02 Month 07 Day

Date of IRB


Anticipated trial start date

2014 Year 02 Month 08 Day

Last follow-up date


Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information



Management information

Registered date

2014 Year 02 Month 10 Day

Last modified on

2014 Year 06 Month 28 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000015266


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name